Clinical Trial Update: Phase-I Study of Radiolabeled DFH-12 (PulmoBind) for Molecular Imaging of the Pulmonary Circulation [Phase 1]

View source ↗

Summary

Phase I study of radiolabeled DFH-12 (PulmoBind) for molecular imaging of the pulmonary circulation. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• PulmoBind (DFH-12)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Pulmonary Disease, Pulmonary Hypertension | Phase 1 | Status: COMPLETED